[1]
|
Beata, B.K., Wojciech, J., Johannes, K., et al. (2023) Alzheimer’s Disease-Biochemical and Psychological Back-ground for Diagnosis and Treatment. International Journal of Molecular Sciences, 24, Article No. 1059.
https://doi.org/10.3390/ijms24021059
|
[2]
|
Yu, T.W., Lane, H.Y. and Lin, C.H. (2021) Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review. International Journal of Molecular Sciences, 22, Article No. 8208. https://doi.org/10.3390/ijms22158208
|
[3]
|
Scheltens, P., De Strooper, B., Kivipelto, M., et al. (2021) Alzheimer’s Disease. The Lancet, 397, 1577-1590.
https://doi.org/10.1016/S0140-6736(20)32205-4
|
[4]
|
Breijyeh, Z. and Karaman, R. (2020) Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules, 25, Article No. 5789. https://doi.org/10.3390/molecules25245789
|
[5]
|
Bakota, L. and Brandt, R. (2016) Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease. Drugs, 76, 301-313. https://doi.org/10.1007/s40265-015-0529-0
|
[6]
|
Mandelkow, E.M. and Mandelkow, E. (1998) Tau in Alz-heimer’s Disease. Trends in Cell Biology, 8, 425-427.
https://doi.org/10.1016/S0962-8924(98)01368-3
|
[7]
|
Martin, L., Latypova, X., Wilson, C.M., et al. (2013) Tau Protein Kinases: Involvement in Alzheimer’s Disease. Ageing Research Reviews, 12, 289-309. https://doi.org/10.1016/j.arr.2012.06.003
|
[8]
|
Mandelkow, E.M. and Mandelkow, E. (1994) Tau Protein and Alzheimer’s Disease. Neurobiology of Aging, 15, S85-S86. https://doi.org/10.1016/0197-4580(94)90178-3
|
[9]
|
Ng, P.Y., Chang, I.S., Koh, R.Y., et al. (2020) Recent Advances in Tau-Directed Immunotherapy against Alzheimer’s Disease: An Overview of Pre-Clinical and Clinical Development. Metabolic Brain Disease, 35, 1049-1066.
https://doi.org/10.1007/s11011-020-00591-6
|
[10]
|
Sery, O., Povova, J., Misek, I., et al. (2013) Molecular Mechanisms of Neuropathological Changes in Alzheimer’s Disease: A Review. Folia Neuropathologica, 51, 1-9. https://doi.org/10.5114/fn.2013.34190
|
[11]
|
Castellani, R.J., Plascencia-Villa, G. and Perry, G. (2019) The Amyloid Cascade and Alzheimer’s Disease Therapeutics: Theory versus Observation. Laboratory Investigation, 99, 958-970. https://doi.org/10.1038/s41374-019-0231-z
|
[12]
|
Passeri, E., Elkhoury, K., Morsink, M., et al. (2022) Alzheimer’s Disease: Treatment Strategies and Their Limitations. International Journal of Molecular Sciences, 23, Article No. 13954. https://doi.org/10.3390/ijms232213954
|
[13]
|
Pinheiro, L. and Faustino, C. (2019) Thera-peutic Strategies Targeting Amyloid-beta in Alzheimer’s Disease. Current Alzheimer Research, 16, 418-452. https://doi.org/10.2174/1567205016666190321163438
|
[14]
|
Yamazaki, Y. and Kanekiyo, T. (2017) Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease. International Journal of Molecular Sciences, 18, Article No. 1965. https://doi.org/10.3390/ijms18091965
|
[15]
|
Sun, X., Chen, W.D. and Wang, Y.D. (2015) beta-Amyloid: The Key Peptide in the Pathogenesis of Alzheimer’s Disease. Frontiers in Pharmacology, 6, Article No. 221. https://doi.org/10.3389/fphar.2015.00221
|
[16]
|
Solis, E.J., Hascup, K.N. and Hascup, E.R. (2020) Alzheimer’s Disease: The Link between Amyloid-beta and Neurovascular Dysfunction. Journal of Alz-heimer’s Disease, 76, 1179-1198. https://doi.org/10.3233/JAD-200473
|
[17]
|
Hamel, E., Nicolakakis, N., Aboulkassim, T., et al. (2008) Oxidative Stress and Cerebrovascular Dysfunction in Mouse Models of Alzheimer’s Disease. Experimental Physiology, 93, 116-120.
https://doi.org/10.1113/expphysiol.2007.038729
|
[18]
|
Love, S. and Miners, J.S. (2016) Cerebrovascular Dis-ease in Ageing and Alzheimer’s Disease. Acta Neuropathologica, 131, 645-658. https://doi.org/10.1007/s00401-015-1522-0
|
[19]
|
Ojo, J.O., Reed, J.M., Crynen, G., et al. (2021) APOE Gen-otype Dependent Molecular Abnormalities in the Cerebrovasculature of Alzheimer’s Disease and Age-Matched Non-Demented Brains. Molecular Brain, 14, Article No. 110.
https://doi.org/10.1186/s13041-021-00803-9
|
[20]
|
Serrano-Pozo, A., Das, S. and Hyman, B.T. (2021) APOE and Alzheimer’s Disease: Advances in Genetics, Pathophysiology, and Therapeutic Approaches. The Lancet Neu-rology, 20, 68-80.
https://doi.org/10.1016/S1474-4422(20)30412-9
|
[21]
|
Hansen, D.V., Hanson, J.E. and Sheng, M. (2018) Mi-croglia in Alzheimer’s Disease. Journal of Cell Biology, 217, 459-472. https://doi.org/10.1083/jcb.201709069
|
[22]
|
Singh, D. (2022) Astrocytic and Microglial Cells as the Modulators of Neuroinflammation in Alzheimer’s Disease. Journal of Neuroinflammation, 19, Article No. 206. https://doi.org/10.1186/s12974-022-02565-0
|
[23]
|
Li, Q., Wu, Y., Chen, J., et al. (2022) Microglia and Im-munotherapy in Alzheimer’s Disease. Acta Neurologica Scandinavica, 145, 273-278. https://doi.org/10.1111/ane.13551
|
[24]
|
Cai, Z., Hussain, M.D. and Yan, L.J. (2014) Microglia, Neuroinflam-mation, and beta-Amyloid Protein in Alzheimer’s Disease. International Journal of Neuroscience, 124, 307-321. https://doi.org/10.3109/00207454.2013.833510
|
[25]
|
Acosta, C. anderson, H.D. and Anderson, C.M. (2017) Astrocyte Dysfunction in Alzheimer Disease. Journal of Neuroscience Research, 95, 2430-2447. https://doi.org/10.1002/jnr.24075
|
[26]
|
Carter, S.F., Herholz, K., Rosa-Neto, P., et al. (2019) Astrocyte Bi-omarkers in Alzheimer’s Disease. Trends in Molecular Medicine, 25, 77-95. https://doi.org/10.1016/j.molmed.2018.11.006
|
[27]
|
Nanclares, C., Baraibar, A.M., Araque, A., et al. (2021) Dysregulation of Astrocyte-Neuronal Communication in Alzheimer’s Disease. International Journal of Molecular Sciences, 22, Article No. 7887.
https://doi.org/10.3390/ijms22157887
|
[28]
|
Batarseh, Y.S., Duong, Q.V., Mousa, Y.M., et al. (2016) Amy-loid-beta and Astrocytes Interplay in Amyloid-beta Related Disorders. International Journal of Molecular Sciences, 17, Article No. 338.
https://doi.org/10.3390/ijms17030338
|
[29]
|
Cai, Z., Wan, C.Q. and Liu, Z. (2017) Astrocyte and Alzheimer’s Disease. Journal of Neurology, 264, 2068-2074.
https://doi.org/10.1007/s00415-017-8593-x
|
[30]
|
Berg-Weger, M. and Stewart, D.B. (2017) Non-Pharmacologic Interventions for Persons with Dementia. Missouri Medicine, 114, 116-119.
|
[31]
|
Shigihara, Y., Hoshi, H., Poza, J., et al. (2020) Predicting the Outcome of Non-Pharmacological Treatment for Patients with De-mentia-Related Mild Cognitive Impairment. Aging (Albany NY), 12, 24101-24116.
https://doi.org/10.18632/aging.202270
|
[32]
|
Akhter-Khan, S.C., Tao, Q., Ang, T., et al. (2021) Associations of Loneliness with Risk of Alzheimer’s Disease Dementia in the Framingham Heart Study. Alzheimer’s & Dementia, 17, 1619-1627. https://doi.org/10.1002/alz.12327
|
[33]
|
Avila-Villanueva, M., Gomez-Ramirez, J., Avila, J., et al. (2022) Loneliness as Risk Factor for Alzheimer’s Disease. Current Aging Science, 15, 293-296. https://doi.org/10.2174/1874609815666220304195049
|
[34]
|
Zhang, Y., Tatewaki, Y., Liu, Y., et al. (2022) Perceived Social Isolation Is Correlated with Brain Structure and Cognitive Trajectory in Alzheimer’s Disease. Geroscience, 44, 1563-1574. https://doi.org/10.1007/s11357-022-00584-6
|
[35]
|
Victor, C.R. (2020) Is Lone-liness a Cause or Consequence of Dementia? A Public Health Analysis of the Literature. Frontiers in Psychology, 11, Article ID: 612771. https://doi.org/10.3389/fpsyg.2020.612771
|
[36]
|
Sutin, A.R., Stephan, Y., Luchetti, M., et al. (2020) Loneliness and Risk of Dementia. Journals of Gerontology—Series B Psychological Sciences and Social Sciences, 75, 1414-1422. https://doi.org/10.1093/geronb/gby112
|
[37]
|
Sundstrom, A., Adolfsson, A.N., Nordin, M., et al. (2020) Loneliness Increases the Risk of All-Cause Dementia and Alzheimer’s Disease. Journals of Ger-ontology—Series B Psychological Sciences and Social Sciences, 75, 919-926.
https://doi.org/10.1093/geronb/gbz139
|
[38]
|
Lara, E., Martin-Maria, N., De la Torre-Luque, A., et al. (2019) Does Loneliness Contribute to Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis of Longitudinal Studies. Ageing Research Reviews, 52, 7-16. https://doi.org/10.1016/j.arr.2019.03.002
|
[39]
|
Moyle, W., Kellett, U., Ballantyne, A., et al. (2011) Dementia and Loneliness: An Australian Perspective. Journal of Clinical Nursing, 20, 1445-1453. https://doi.org/10.1111/j.1365-2702.2010.03549.x
|
[40]
|
Ball, E.L., Owen-Booth, B., Gray, A., et al. (2020) Aromatherapy for Dementia. Cochrane Database of Systematic Reviews, 8, D3150. https://doi.org/10.1002/14651858.CD003150.pub3
|
[41]
|
Yang, M.H., Lin, L.C., Wu, S.C., et al. (2015) Com-parison of the Efficacy of Aroma-Acupressure and Aromatherapy for the Treatment of Dementia-Associated Agi-tation. BMC Complementary and Alternative Medicine, 15, Article No. 93. https://doi.org/10.1186/s12906-015-0612-9
|
[42]
|
Fung, J. and Tsang, H.W. (2018) Management of Behavioural and Psychological Symptoms of Dementia by an Aroma-Massage with Acupressure Treatment Protocol: A Ran-domised Clinical Trial. Journal of Clinical Nursing, 27, 1812-1825. https://doi.org/10.1111/jocn.14101
|
[43]
|
Jimbo, D., Kimura, Y., Taniguchi, M., et al. (2009) Effect of Aro-matherapy on Patients with Alzheimer’s Disease. Psychogeriatrics, 9, 173-179. https://doi.org/10.1111/j.1479-8301.2009.00299.x
|
[44]
|
Ebihara, T., Yamasaki, M., Kozaki, K., et al. (2021) Medical Aromatherapy in Geriatric Syndrome. Geriatrics & Gerontology International, 21, 377-385. https://doi.org/10.1111/ggi.14157
|
[45]
|
Faridzadeh, A., Salimi, Y., Ghasemirad, H., et al. (2022) Neuroprotec-tive Potential of Aromatic Herbs: Rosemary, Sage, and Lavender. Frontiers in Neuroscience, 16, Article ID: 909833. https://doi.org/10.3389/fnins.2022.909833
|
[46]
|
Ghasemzadeh, R.M. and Hosseinzadeh, H. (2020) Therapeu-tic Effects of Rosemary (Rosmarinus officinalis L.) and Its Active Constituents on Nervous System Disorders. Ira-nian Journal of Basic Medical Sciences, 23, 1100-1112.
|
[47]
|
Urakami, K. (2022) Dementia Prevention and Aro-matherapy in Japan. Yonago Acta Medica, 65, 184-190.
https://doi.org/10.33160/yam.2022.08.001
|
[48]
|
Wang, L.Y., Pei, J., Zhan, Y.J., et al. (2020) Overview of Meta-Analyses of Five Non-Pharmacological Interventions for Alzheimer’s Disease. Frontiers in Aging Neurosci-ence, 12, Article ID: 594432.
https://doi.org/10.3389/fnagi.2020.594432
|
[49]
|
Teja, Y., Helianthi, D.R. and Nareswari, I. (2021) The Role of Medical Acupuncture Therapy in Alzheimer’s Disease. Medical Acupuncture, 33, 396-402. https://doi.org/10.1089/acu.2021.0014
|
[50]
|
Zhou, H., Sun, G., Kong, L., et al. (2014) Acupuncture and Moxibustion Reduces Neuronal Edema in Alzheimer’s Disease Rats. Neural Regeneration Research, 9, 968-972. https://doi.org/10.4103/1673-5374.133148
|
[51]
|
Harris, M.L., Titler, M.G. and Struble, L.M. (2020) Acu-puncture and Acupressure for Dementia Behavioral and Psychological Symptoms: A Scoping Review. Western Journal of Nursing Research, 42, 867-880.
https://doi.org/10.1177/0193945919890552
|
[52]
|
Yin, W., Lv, G., Li, C., et al. (2021) Acupuncture Therapy for Alzheimer’s Disease: The Effectiveness and Potential Mechanisms. The Anatomical Record (Hoboken), 304, 2397-2411. https://doi.org/10.1002/ar.24780
|
[53]
|
Wuli, W., Harn, H.J., Chiou, T.W., et al. (2021) Chinese Herbs and Acupuncture to Improve Cognitive Function in Alzheimer’s Disease. Tzu Chi Medical Journal, 33, 122-127. https://doi.org/10.4103/tcmj.tcmj_51_20
|
[54]
|
Yakimicki, M.L., Edwards, N.E., Richards, E., et al. (2019) Animal-Assisted Intervention and Dementia: A Systematic Review. Clinical Nursing Research, 28, 9-29. https://doi.org/10.1177/1054773818756987
|
[55]
|
Rodrigo-Claverol, M., Malla-Clua, B., Marquilles-Bonet, C., et al. (2020) Animal-Assisted Therapy Improves Communication and Mobility among Institutionalized People with Cognitive Impairment. International Journal of Environmental Research and Public Health, 17, Article No. 5899. https://doi.org/10.3390/ijerph17165899
|
[56]
|
Nordgren, L. and Engstrom, G. (2014) Animal-Assisted Inter-vention in Dementia: Effects on Quality of Life. Clinical Nursing Research, 23, 7-19. https://doi.org/10.1177/1054773813492546
|
[57]
|
Park, S., Bak, A., Kim, S., et al. (2020) Animal-Assisted and Pet-Robot Interventions for Ameliorating Behavioral and Psychological Symptoms of Dementia: A Systematic Re-view and Meta-Analysis. Biomedicines, 8, Article No. 150.
https://doi.org/10.3390/biomedicines8060150
|
[58]
|
Scales, K., Zimmerman, S. and Miller, S.J. (2018) Evi-dence-Based Nonpharmacological Practices to Address Behavioral and Psychological Symptoms of Dementia. Gerontologist, 58, S88-S102. https://doi.org/10.1093/geront/gnx167
|
[59]
|
Nordgren, L. and Engstrom, G. (2012) Effects of Animal-Assisted Therapy on Behavioral and/or Psychological Symptoms in Dementia: A Case Report. American Journal of Alzheimer’s Disease & Other Dementias, 27, 625-632.
https://doi.org/10.1177/1533317512464117
|
[60]
|
Buettner, L.L., Fitzsimmons, S. and Barba, B. (2011) Ani-mal-Assisted Therapy for Clients with Dementia. Journal of Gerontological Nursing, 37, 10-14. https://doi.org/10.3928/00989134-20110329-05
|
[61]
|
Kim, S., Nam, Y., Ham, M.J., et al. (2021) Neurological Mechanisms of Animal-Assisted Intervention in Alzheimer’s Disease: A Hypothetical Review. Frontiers in Aging Neuroscience, 13, Article ID: 682308.
https://doi.org/10.3389/fnagi.2021.682308
|
[62]
|
Lai, N.M., Chang, S., Ng, S.S., et al. (2019) Animal-Assisted Therapy for Dementia. Cochrane Database of Systematic Reviews, 2019, CD013243. https://doi.org/10.1002/14651858.CD013243.pub2
|
[63]
|
Swall, A., Ebbeskog, B., Lundh, H.C., et al. (2017) Stepping Out of the Shadows of Alzheimer’s Disease: A Phenomenological Hermeneutic Study of Older People with Alzheimer’s Disease Caring for a Therapy Dog. International Journal of Qualitative Studies on Health and Well-Being, 12, Article ID: 1347013.
https://doi.org/10.1080/17482631.2017.1347013
|
[64]
|
Takeda, M., Tanaka, T., Okochi, M., et al. (2012) Non-Pharmacological Intervention for Dementia Patients. Psychiatry and Clinical Neurosciences, 66, 1-7. https://doi.org/10.1111/j.1440-1819.2011.02304.x
|
[65]
|
Maseda, A., Cibeira, N., Lorenzo-Lopez, L., et al. (2018) Multisensory Stimulation and Individualized Music Sessions on Older Adults with Severe Dementia: Effects on Mood, Behavior, and Biomedical Parameters. Journal of Alzheimer’s Disease, 63, 1415-1425. https://doi.org/10.3233/JAD-180109
|
[66]
|
Maseda, A., Sanchez, A., Marante, M.P., et al. (2014) Effects of Multisensory Stimulation on a Sample of Institutionalized Elderly People with Dementia Diagnosis: A Controlled Longitudinal Trial. American Journal of Alzheimer’s Disease & Other Dementias, 29, 463-473. https://doi.org/10.1177/1533317514522540
|
[67]
|
Sanchez, A., Marante-Moar, M.P., Sarabia, C., et al. (2016) Multisensory Stimulation as an Intervention Strategy for Elderly Patients with Severe Dementia: A Pilot Randomized Controlled Trial. American Journal of Alzheimer’s Disease & Other Dementias, 31, 341-350. https://doi.org/10.1177/1533317515618801
|
[68]
|
Silva, R., Abrunheiro, S., Cardoso, D., et al. (2018) Effec-tiveness of Multisensory Stimulation in Managing Neuropsychiatric Symptoms in Older Adults with Major Neu-rocognitive Disorder: A Systematic Review. JBI Database of Systematic Reviews and Implementation Reports, 16, 1663-1708. https://doi.org/10.11124/JBISRIR-2017-003483
|
[69]
|
Sanchez, A., Millan-Calenti, J.C., Lo-renzo-Lopez, L., et al. (2013) Multisensory Stimulation for People with Dementia: A Review of the Literature. American Journal of Alzheimer’s Disease & Other Dementias, 28, 7-14.
https://doi.org/10.1177/1533317512466693
|
[70]
|
Machado, B.M. and Castro, C. (2022) Use of Multisensory Stimulation in Institutionalized Older Adults with Moderate or Severe Dementia. Dementia & Neuropsychologia, 16, 202-212. https://doi.org/10.1590/1980-5764-dn-2021-0022
|
[71]
|
Rodriguez-Gonzalez, V., Gomez, C., Hoshi, H., et al. (2021) Exploring the Interactions between Neurophysiology and Cognitive and Behavioral Changes In-duced by a Non-Pharmacological Treatment: A Network Approach. Frontiers in Aging Neuroscience, 13, Article ID: 696174. https://doi.org/10.3389/fnagi.2021.696174
|
[72]
|
Herholz, S.C., Herholz, R.S. and Herholz, K. (2013) Non-Pharmacological Interventions and Neuroplasticity in Early Stage Alzheimer’s Disease. Expert Review of Neurotherapeutics, 13, 1235-1245.
https://doi.org/10.1586/14737175.2013.845086
|
[73]
|
Shigihara, Y., Hoshi, H., Shinada, K., et al. (2020) Non-Pharmacological Treatment Changes Brain Activity in Patients with Dementia. Scientific Reports, 10, Article No. 6744. https://doi.org/10.1038/s41598-020-63881-0
|